NEW YORK (GenomeWeb) – PerkinElmer said today that it has inked a definitive agreement to acquire Lübeck, Germany-based Euroimmun Medical Laboratory Diagnostics for about $1.3 billion in cash.

Euroimmun is recognized as a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing, and has "extensive expertise and capabilities" across immunology, cell biology, histology, biochemistry, and molecular biology, PerkinElmer said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.